Pedi CardioRef
Reference: ACC/AHA Sports Participation Recommendations, Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic RV Cardiomyopathy and other Cardiomyopathies, and Myocarditis (Circulation 2015)

participate in organized sports?

Should my patient with Hypertrophic Cardiomyopathy participate in organized sports?

Need to know:

⬋
⬊

With LV Hypertrophy

"Athletes with a probable or unequivocal clinical expression and diagnosis of HCM (ie, with the disease phenotype of LV hypertrophy) should not participate in most competitive sports, with the exception of those of low intensity (class IA sports)"

"This recommendation is independent of age, sex, magnitude of LV hypertrophy, particular sarcomere mutation, presence or absence of LV outflow obstruction (at rest or with physiological exercise), absence of prior cardiac symptoms, presence or absence of late gadolinium enhancement (fibrosis) on CMR, and whether major interventions such as surgical myectomy or alcohol ablation have been performed previously."

Non-Class IA = Inadvisable

Class IA sports: Bowling, Cricket, Curling, Golf, Riflery, Yoga = Acceptable

(Class III Recommendation; Level of Evidence C)

Without LV Hypertrophy

"Participation in competitive athletics for asymptomatic, genotype-positive HCM patients without evidence of LV hypertrophy by 2-dimensional echocardiography and CMR is reasonable, particularly in the absence of a family history of HCM-related sudden death ."

Non-Class IA = Maybe (see conditions above)

(Class IIa Recommendation; Level of Evidence C)


Not Recommended

The following are NOT recommended:

Beta Blocker for sport: Pharmacologic agents to control cardiac-related symptoms or ventricular tachyarrhythmias should NOT be administered for the sole purpose of permitting participation in high-intensity sports. Notably, such drugs may also be inconsistent with maximal physical performance in most sports

Prophylactic ICD: Should not be placed in athletes with HCM for the sole or primary purpose of permitting participation in high-intensity sports competition because of the possibility of device-related complications. ICD indications for competitive athletes with HCM should not differ from those in nonathlete patients with HCM.

Reference: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis. A Scientific Statement From the AHA and ACC. Circulation 2015

Disclaimer: This website is derived from published guidelines, but does not constitute medical advice nor does it replace clinical judgement. Only the text in quotation marks are direct quotations from the original guidelines. Text not in quotations as well as the method of information display are all that of the website creator and are not part of the original published guidelines. Please consult a physician to discuss any patient-specific matters.

Key: LV = left ventricle, LVH = left ventricular hypertrophy, HCM = hypertrophic cardiomyopathy, ICD = implantable cardio defibrilator, echo = echocardiogram, CMR = cardiac MRI